Reported Dec 2, 2020 · Terminated

clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista…

Jubilant Cadista Pharmaceuticals, Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Jubilant Cadista Pharmaceuticals, Inc. · 207 Kiley Dr · Salisbury, MD · 21801-2249

Is this the product you have?

  • clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only
  • Manufactured byJubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30
Lot codes and dates
    • Lot# 20P0141
    • exp. date 02/2022
Amount recalled
4,416 bottles

Where it was sold

  • Nationwide

Why it was recalled

Failed Tablet/Capsule Specification

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Jubilant Cadista Pharmaceuticals, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Mar 23, 2022 · Data as of Sep 19, 8:07 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.